Day: March 24, 2022
MELVILLE, N.Y., March 24, 2022 (GLOBE NEWSWIRE) — Data Storage Corporation (Nasdaq: DTST) (“DSC” and the “Company”), a provider of diverse business continuity solutions for disaster-recovery, cloud infrastructure, cyber-security and data analytics solutions, today announced that it plans to host a conference call at 10:00 am ET on Thursday, March 31, 2022 to discuss the company’s financial results for the 2021 fiscal year ended December 31, 2021, as well as corporate progress and other developments.
The conference call will be available via telephone by dialing toll free 888-506-0062 for U.S. callers or for international callers +1 973-528-0011 and using entry code: 283625. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2763/44979, or on the Company’s Investor Relations section of the website, ir.datastoragecorp.com.
A...
ibex Unveils Augment by ibex for On-Demand Staff Augmentation and Managed Services
Written by Customer Service on . Posted in Public Companies.
Delivers High-Demand Specialized Talent and Strategic Managed Services Globallyibex Unveils Augment by ibex for On-Demand Staff Augmentation and Managed Services
Augment by ibex provides specialized dedicated talent for high-demand professional and administration functions, ranging from IT and engineering to cyber security, marketing, data analytics, and data science.WASHINGTON, March 24, 2022 (GLOBE NEWSWIRE) — ibex (NASDAQ: IBEX), a leading global provider of business process outsourcing (BPO) and customer engagement technology solutions, today announced the launch of Augment by ibex, the company’s staff augmentation and managed services offering. Augment by ibex provides specialized dedicated talent for high-demand professional and administration functions, ranging from IT and engineering to cyber security, marketing,...
Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022
Written by Customer Service on . Posted in Public Companies.
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) — Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines, announced today that the Company will host a conference call at 11:00 a.m. ET on Thursday, March 31, 2022 to discuss financial results for the year ended December 31, 2021 and provide an update on product development programs with GEN-1, a DNA-based immunotherapy, currently in Phase II development for the localized treatment of advanced ovarian cancer and PLACCINE, a proprietary synthetic, non-viral vaccine delivery technology currently in preclinical studies. Celsion has two platform technologies for the development of novel nucleic acid-based immunotherapies and next generation infectious vaccines.
To participate in the call, interested...
Canadian nonprofits are investing in digital transformation to drive efficiency and growth, Sage study finds
Written by Customer Service on . Posted in Public Companies.
Pandemic has pushed organizations to seek new ways to work and deliver services
TORONTO, March 24, 2022 (GLOBE NEWSWIRE) — Sage (FTSE: SGE), the leader in accounting, financial, HR and payroll technology for small and mid-sized businesses, today released a new study on the Canadian nonprofit sector, Grow Together: How digital transformation empowers Canadian nonprofit organizations to embrace change. The study found that nonprofits have seized the opportunity during the pandemic to rethink and change the way they operate to gain efficiencies and better serve their communities, despite the difficulties caused by COVID-19.
Transforming operations to overcome challenges
In partnership with Leger, a Canadian research firm, Sage found that 9 in 10 nonprofits consider their digital transformation efforts a top priority to update business...
EVmo Expands Fleet through Agreements with Leading OEMs to Supply Vehicles in Support of Growth Quarterly Plans
Written by Customer Service on . Posted in Public Companies.
LOS ANGELES, March 24, 2022 (GLOBE NEWSWIRE) — EVmo, Inc. (OTC: YAYO) (the “Company’), a leading provider of vehicles to the rideshare and delivery gig economy industry, today announced a agreements with leading automobile manufacturers to supply the Company with approximately 400 new vehicles quarterly.
“We are thrilled to have agreements with multiple leading OEMs to provide a steady supply of new vehicles to grow our fleet, an important component of our expansion strategy as we enter new markets in the months ahead,” commented Steven Sanchez, CEO of EVmo. “The commitments for these vehicles were made possible by the non-dilutive financing we announced earlier in March. These agreements give us tremendous confidence in our ability to achieve our goal of adding 400 vehicles to our fleet each quarter during 2022. This month’s order...
Aspo Plc – Managers’ transactions – Arto Meitsalo
Written by Customer Service on . Posted in Public Companies.
Aspo Plc Managers’ transactionsMarch 24, 2022, at 3 p.m.
Aspo Plc – Managers’ transactions – Arto Meitsalo
Person subject to the notification requirement
Name: Meitsalo Arto
Position: Chief Financial Officer
Issuer: Aspo Oyj
LEI: 7437000TB0GHDHLPX677
Notification type: INITIAL NOTIFICATION
Reference number: 7437000TB0GHDHLPX677_20220322131347_2
____________________________________________
Transaction date: 2022-03-23
Venue not applicable
Instrument type: SHARE
ISIN: FI0009008072
Nature of the transaction: RECEIPT OF A SHARE-BASED INCENTIVE OR REMUNERATION
Transaction details
(1): Volume: 9,900 Unit price: EUR
Aggregated transactions
(1): Volume: 9,900 Volume weighted average price: EUR
Aspo Plc
Rolf Jansson CEO
Further information, please contact:
Rolf Jansson, CEO, Aspo Plc, +358 400 600 264, rolf.jansson@aspo.com
Distribution:...
IQST – iQSTEL Announces 3 Target Acquisitions Expected To Close Next Month
Written by Customer Service on . Posted in Public Companies.
New York, NY, March 24, 2022 (GLOBE NEWSWIRE) — iQSTEL, Inc. (OTCQX: IQST) today announced the company expects to close three acquisitions prior to the end of April 2022. CEO Leandro Iglesias has issued a update today as part of his regular series of updates detailing the company’s ongoing progress toward its $90 million 2022 annual revenue forecast and uplisting to Nasdaq in the first half of this year. The update is included in its entirety below:
Dear Shareholders:
The first fiscal quarter of 2022 is drawing to a conclusion and in spite of the prevailing market conditions and world events, I am pleased to share that iQSTEL is well on track to achieve its 2022 objectives. Nothing is standing in the way of our $90 million 2022 annual revenue forecast or Nasdaq uplisting.
Permit me to share some highlights.
Our new electric vehicle...
Non-Executive Director – External Appointment
Written by Customer Service on . Posted in Public Companies.
NON-EXECUTIVE DIRECTOR – EXTERNAL APPOINTMENT
London, 24 March 2022 – Endeavour Mining plc (LSE: EDV) (“the Company”) announces, in accordance with UK Listing Rule 9.6.14, that Alison Baker, an independent non-executive director of the Company, has notified the Company that she has been appointed to the board of Capstone Copper Corporation, a company admitted to trading on the Toronto Stock Exchange, with effect from 23 March 2022.
CONTACT INFORMATIONEndeavour Mining Martino De CiccioVice President – Strategy & Investor Relations+44 203 640 8665mdeciccio@endeavourmining.com
Brunswick Group LLP in LondonCarole Cable, Partner+44 7974 982 458ccable@brunswickgroup.com
Vincic Advisors in TorontoJohn Vincic, Principal+1 647 402 6375john@vincicadvisors.comABOUT ENDEAVOUR MINING PLC
Endeavour is one...
InflaRx Reports Full Year 2021 Financial and Operating Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Company received corrected FDA advice letter for Phase III trial with vilobelimab in hidradenitis suppurativa
Positive Phase IIa data reported with vilobelimab in pyoderma gangrenosum; data being presented as late-breaker oral presentation at AAD Annual Meeting
Topline data in vilobelimab Phase III trial in severe COVID-19 expected by end of March
Both US and EU Phase II trials with vilobelimab in AAV met their objectives
Phase II trial with vilobelimab in cSCC enrolling with first efficacy data expected later this year
New program, INF904 oral small molecule inhibitor of C5aR, recently introduced
Year-end cash and cash equivalents of approximately €26.2 million and financial assets of approximately €84.4 millionJENA, Germany, March 24, 2022 (GLOBE NEWSWIRE) — InflaRx N.V. (Nasdaq: IFRX), a clinical-stage biopharmaceutical company...
Pieridae Releases Q4 and 2021 Results
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
Upstream Focused Company with a Viable LNG OptionNew President & COO and CFO Promotions Announced
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN UNITED STATES
Key Highlights:Generated $57.7 million Adjusted Funds Flow from Operations1 (“AFFO”) in 2021 an increase of 115% year over year from $26.9 million in 2020 to $57.7 million
Generated $84.1 million Net Operating Income1 (“NOI”) in 2021, an increase of 66% year over year, from $50.7 million in 2020
Increased petroleum and natural gas revenue to $334.7 million in 2021 up 41% from $238.1 million in 2020
Production averaged 40,562 barrels of oil equivalent per day (“boe/d”) in 2021 , a marginal decrease from 42,000 boe/d in 2020 in the midst of two planned facility turnarounds or planned maintenance shutdowns
The proved developed producing (“PDP”) base...